Meichen X. Zhang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy.
Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy.
Journal: Frontiers in chemistry
Published: December 05, 2022
Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia.
Journal: Pharmacological research
Published: August 11, 2022
Fibrinogen gamma-chain mutation, p.Ile171His, leads to hereditary hypofibrinogenemia
Journal: Zhonghua nei ke za zhi
Published: January 28, 2022
Clinical characteristics and prognosis of MLL-AF6 positive patients with acute myeloid leukemia
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: October 15, 2021
A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia.
Journal: Journal of hematology & oncology
Published: September 20, 2021
Efficacy and safety analysis of the combination of cladribine, cytarabine, granulocyte colonystimulating factor (CLAG) regime in patients with refractory or relapsed acute myeloid leukemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 19, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026